Study Summary:
Accelovance is researching a new oral supplement that could help suppress some symptoms of Diarrhea Predominant IBS.
Qualified Participants Must:
Suffer from diarrhea predominant IBS
Qualified Participants May Receive:
Compensation up to $200, supplements or placebo, and study related physician care at no cost.